---
schema_version: "secwatch.filing_event.v1"
accession: "0001847903-25-000003"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T07:05:53.844940+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Centessa posts corporate slide presentation; no material updates disclosed

## Summary
- Filing under Regulation FD discloses current corporate slide presentation as of Jan 8, 2025.
- No specific financial or operational updates are included in the filing text.
- Slide presentation is available on the company's investor relations website.

## SEC filing metadata
- accession: 0001847903-25-000003
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000184790325000003/0001847903-25-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000184790325000003/cnta-20250108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001847903-25-000003
- JSON: https://secwatch.observer/filing/0001847903-25-000003.json
- Plain text: https://secwatch.observer/filing/0001847903-25-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.